This is an information message
We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.
MANILA, Philippines — Government is mounting a probe on a member of the House of Representatives who had been among the first recipients of the coronavirus vaccine that was reserved for health care workers. Vaccine czar Carlito…
Since October 2020, I’ve been working with the private sector on the national vaccine program with vaccine czar Secretary Carlito Galvez Jr. and his team. We’ve focused our efforts on creating a vaccine portfolio, vaccine administration and…
CEBU CITY, Philippines — Cebu City Vice Mayor Michael Rama said he does not need to become the vaccine czar in order to work with the Vaccine Board in preparing for the roll-out of the COVID-19 vaccines…
CEBU CITY, Philippines — Cebu City Mayor Edgardo Labella has named Vice Mayor Michael Rama as the city’s vaccine czar. This amid the recent exchange of heated statements between the two officials over the weekend. “We are…
During the past few days, the “Man of the Hour” has been former AFP chief of staff, Gen. Carlito Galvez Jr., who has been facing a Senate inquiry on the government’s vaccination program. In March 2020, General…
BACOLOD CITY – The national president of the League of Cities of the Philippines (LCP) has called for a virtual general assembly of city mayors on Tuesday, January 12, to meet with national officials to discuss the…
Two things are to be considered in the envisioned nationwide mass immunization against COVID-19: First, it has to be depoliticized—completely, if possible; and second, the source of the vaccine has to be diversified, which means it should…
MANILA, Philippines — The Philippine government, together with local private companies, will sign a tripartite agreement with British drugmaker AstraZeneca on Friday for the purchase of its COVID-19 vaccine. The country’s vaccine czar Secretary Carlito Galvez Jr.…
This is an information message
We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.